Serum/plasma microRNAs as biomarkers for lung cancer

Chinese Journal of Lung Cancer

Volumn 15, Issue 1, 2012, Pages 52-55

  Zhang, Hui ^a   Chen, Xiaofeng ^a  

^a SHANGHAI PULMONARY HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA;

ARTICLE; LUNG CANCER;

EID: 84962594092     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2012.01.11     Document Type: Article

References (31)

1. Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin, 2010, 60(5): 277-300.
2. Chen WQ, Zhang SW, Zou XN, et al. Estimation and projection of lung cancer incidence and mortality in China. Chin J Lung Cancer, 2010, 13(5): 488-493.
3. Ettinger DS, Akerley W, Bepler G, et al. Non-small cell lung cancer. J Natl Compr Canc Netw, 2010, 8(7): 740-801.
4. Chen X, Hu Z, Wang W, et al. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel non-invasive biomarkers for non-small cell lung cancer diagnosis. Int J Cancer, 2011. [Epub ahead of print].
5. Swensen SJ, Jett JR, Hartman TE, et al. CT screening for lung cancer: five- year prospective experience. Radiology, 2005, 235(1): 259-265.
6. Boeri M, Verri C, Conte D, et al. MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc Natl Acad Sci USA, 2011, 108(9): 3713-3718.
7. Reid G, Kirschner MB, van Zandwijk N. Circulating microRNAs: Association with disease and potential use as biomarkers. Crit Rev Oncol Hematol, 2011, 80(2): 193-208.
8. Turchinovich A, Weiz L, Langheinz A, et al. Characterization of extracellular circulating microRNA. Nucleic Acids Res, 2011, 39(16): 7223-7233.
9. Chen X, Ba Y, Ma L, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res, 2008, 18(10): 997-1006.
10. Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA, 2008, 105(30): 10513-10518.
11. Ho AS, Huang X, Cao H, et al. Circulating miR-210 as a novel hypoxia marker in pancreatic cancer. Transl Oncol, 2010, 3(2): 109-113.
12. Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol, 2008, 110(1): 13-21.
13. Huang Z, Huang D, Ni S, et al. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer, 2010, 127(1): 118-126.
14. Gilad S, Meiri E, Yogev Y, et al. Serum microRNAs are promising novel biomarkers. PLoS One, 2008, 3(9): e3148.
15. Rabinowits G, Gercel-Taylor C, Day JM, et al. Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer, 2009, 10(1): 42-46.
16. Chen TS, Lai RC, Lee MM, et al. Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs. Nucleic Acids Res, 2010, 38(1): 215-224.
17. Yuan A, Farber EL, Rapoport AL, et al. Transfer of microRNAs by embryonic stem cell microvesicles. PLoS One, 2009, 4(3): e4722.
18. Wang K, Zhang S, Weber J, et al. Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res, 2010, 38(20): 7248-7259.
19. Arroyo JD, Chevillet JR, Kroh EM, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA, 2011, 108(12): 5003-5008.
20. Shen J, Todd NW, Zhang H, et al. Plasma microRNAs as potential biomark-ers for non-small-cell lung cancer. Lab Invest, 2011, 91(4): 579-587.
21. Wang J, Chen J, Chang P, et al. MicroRNAs in plasma of pancreatic ductal ad- enocarcinoma patients as novel blood-based biomarkers of disease. Cancer Prev Res (Phila), 2009, 2(9): 807-813.
22. Wei J, Gao W, Zhu CJ, et al. Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer. Chin J Cancer, 2011, 30(6): 407-414.
23. Foss KM, Sima C, Ugolini D, et al. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer. J Thorac Oncol, 2011, 6(3): 482-488.
24. Kroh EM, Parkin RK, Mitchell PS, et al. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods, 2010, 50(4): 298-301.
25. Pall GS, Hamilton AJ. Improved northern blot method for enhanced detec- tion of small RNA. Nat Protoc, 2008, 3(6): 1077-1084.
26. Chen C, Ridzon DA, Broomer AJ, et al. Real-time quantification of microR- NAs by stem-loop RT-PCR. Nucleic Acids Res, 2005, 33(20): e179.
27. Jamnikar Ciglenecki U, Grom J, Toplak I, et al. Real-time RT-PCR assay for rapid and specific detection of classical swine fever virus: comparison of SYBR Green and TaqMan MGB detection methods using novel MGB probes. J Virol Methods, 2008, 147(2): 257-264.
28. Hafner M, Landgraf P, Ludwig J, et al. Identification of microRNAs and other small regulatory RNAs using cDNA library sequencing. Methods, 2008, 44(1): 3-12.
29. Keller A, Leidinger P, Gislefoss R, et al. Stable serum miRNA profiles as potential tool for non-invasive lung cancer diagnosis. RNA Biol, 2011, 8(3): 506-516.
30. Roth C, Kasimir-Bauer S, Pantel K, et al. Screening for circulating nucleic ac- ids and caspase activity in the peripheral blood as potential diagnostic tools in lung cancer. Mol Oncol, 2011, 5(3): 281-291.
31. Heneghan HM, Miller N, Kerin MJ. Circulating miRNA signatures: promis- ing prognostic tools for cancer. J Clin Oncol, 2010, 28(29): e573-e574.